Shi, K., Sun, Q., Qiao, C., Zhu, H., Wang, L., Wu, J., . . . Li, J. (2019). 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia. Cancer Med.
Citação norma ChicagoShi, Ke, et al. "98% IGHV Gene Identity Is the Optimal Cutoff to Dichotomize the Prognosis of Chinese Patients With Chronic Lymphocytic Leukemia." Cancer Med 2019.
MLA CitationShi, Ke, et al. "98% IGHV Gene Identity Is the Optimal Cutoff to Dichotomize the Prognosis of Chinese Patients With Chronic Lymphocytic Leukemia." Cancer Med 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.